Share this page

Twitter Facebook

The Global Fund strategy is a multi-year roadmap for the partnership’s future. The strategy sets out priorities for how the Global Fund partnership can accelerate progress against HIV, TB and malaria and improve global health. It also includes ambitious goals and targets to measure progress.

The Global Fund Strategy 2017-2022:
Investing to End Epidemics

In April 2016, the Board of the Global Fund unanimously approved the organization’s strategy for the period 2017 to 2022, titled Investing to End Epidemics.

The strategy is based on a framework of four clear objectives:

The strategy was developed through an extensive consultation process which took place throughout 2015 and the early part of 2016. Not only did we reach out to donors, technical partners, communities affected by the diseases, and implementers, but we also held a series of three Partnership Forums during the course of 2015. Themes which emerged from these consultations with a broad range of stakeholders include: the need to better address challenges faced by women and girls; the need to support resilient and sustainable systems for health; and the need to strengthen work on sustainability and human rights.

With the approval of the strategy, the next step is to work out how best to operationalize these goals and to develop a key performance indicator framework that will allow us to measure progress on the fulfillment of these ambitions.

The Global Fund Strategy outlines a bold agenda for 2017 to 2022 that is based on an ambitious vision. It is built on a framework of four strategic objectives, each underpinned by a number of sub-objectives and supported by two strategic enablers.

  • The Global Fund Strategy 2017-2022: Investing to End Epidemics
    download in English

We are now implementing the new strategy and recently received the first applications from countries to review and begin implementing for impact.

In March 2017, the Global Fund Board approved the new performance targets for the Global Fund Strategy 2017-2022. Programs supported by the Global Fund will save 14 million lives in the three-year period beginning in 2017, bringing the total lives saved by the Global Fund partnership to 36 million by the end of 2019. Those programs will also avert up to 194 million new infections or cases of HIV, TB and malaria. Global Fund support will further catalyze US$35 billion in domestic finance for health and drive US$230 billion in economic gains.

Updated projections show that every US$100 million invested in Global Fund-supported programs will:

  • Save 133,000 lives through programs supported by the Global Fund, and;
  • Avert 1.9 million new infections or cases across the three diseases, and;
  • Spur domestic investment of US$300 million toward the three diseases, and;
  • Create US$2.2 billion in long-term economic gains, and;
  • Provide antiretroviral therapy for 107,000 people, and;
  • Provide treatment for 31,000 women to prevent passing HIV to their babies, and;
  • Provide TB treatment and care for 153,000 people, and;
  • Provide 4,300 people with treatment for multidrug-resistant TB, and;
  • Distribute 6.2 million mosquito nets to protect children and families from malaria, and;
  • Provide indoor residual spraying for 1.2 million households to protect children and families from malaria.

Published 01 May 2017